These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

120 related items for PubMed ID: 4660197

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Spironolactone and hydrochlorothiazide in essential hypertension. Blood pressure response and plasma renin activity.
    Adlin EV, Marks AD, Channick BJ.
    Arch Intern Med; 1972 Dec; 130(6):855-8. PubMed ID: 5082465
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Spironolactone and hydrochlorothiazide in normal-renin and low-renin essential hypertension.
    Ferguson RK, Turek DM, Rovner DR.
    Clin Pharmacol Ther; 1977 Jan; 21(1):62-9. PubMed ID: 318952
    [Abstract] [Full Text] [Related]

  • 10. [Spironolactone and thiabutazide in the treatment of essential hypertension (author's transl)].
    Klump F, Braun B, Klaus D, Lemke R, Zehner J, Zöfel P.
    Dtsch Med Wochenschr; 1975 Mar 21; 100(12):577-84. PubMed ID: 1168122
    [Abstract] [Full Text] [Related]

  • 11. [Correlations between blood pressure, blood volume and plasma renin during therapy with diuretics in essential hypertension. Comparison between the mineralocorticoid antagonist spironolactone and the "loop" diuretic mefruside].
    Beretta-Piccoli C, Weidmann P, de Châtel R, Hirsch D, Reubi FC.
    Schweiz Med Wochenschr; 1977 Jan 29; 107(4):104-15. PubMed ID: 834983
    [Abstract] [Full Text] [Related]

  • 12. Reduced response of plasma aldosterone to acute ACTH stimulation during long-term treatment with spironolactone in essential hypertension.
    Kim KS, Morimoto S, Uchida K, Miyamori I, Miyamoto M, Takeda R.
    Horm Res; 1979 Jan 29; 11(1):4-11. PubMed ID: 225255
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. The patient with mild to moderate essential hypertension: peripheral renin activity and a comparative drug study.
    Merkle GW, Bader PI, Creason PL, Townsend DW, Conn PS, Lakes MK, Campbell NM.
    J Indiana State Med Assoc; 1981 Jul 29; 74(7):444-9. PubMed ID: 7024422
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Plasma aldosterone in essential hypertension with low renin activity.
    Fukuchi S, Nakajima K, Takenouchi T, Nishisato K.
    Jpn Circ J; 1974 Dec 29; 38(12):1071-7. PubMed ID: 4436936
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Suppressed plasma renin activity in essential hypertension. Roles of plasma volume, blood pressure, and sympathetic nervous system.
    Jose A, Crout JR, Kaplan NM.
    Ann Intern Med; 1970 Jan 29; 72(1):9-16. PubMed ID: 4312105
    [No Abstract] [Full Text] [Related]

  • 20. The effect of potassium chloride and spironolactone on the thiazide-induced potassium depletion in patients with essential hypertension.
    Ibsen H.
    Acta Med Scand; 1974 Jan 29; 196(1-2):21-6. PubMed ID: 4419560
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.